Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
02/2012
02/16/2012US20120039902 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
02/16/2012US20120039901 Method for the prevention and treatment of cancer by inhibition of gpvi
02/16/2012US20120039900 Biomarkers predictive of the responsiveness to tnfalpha inhibitors in autoimmune disorders
02/16/2012US20120039899 Anti-Hemagglutinin Antibody Compositions And Methods Of Use Thereof
02/16/2012US20120039898 Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
02/16/2012US20120039897 Method of treatment of neurodementing diseases using isolated, monoclonal, human, anti-b-amyloid antibody
02/16/2012US20120039896 Method for inhibiting cellular activation by insulin-like growth factor-1
02/16/2012US20120039895 Phosphorycholine conjugates and corresponding antibodies
02/16/2012US20120039894 Identification of therapeutic agents for hiv infection
02/16/2012US20120039893 Mutant smoothened and methods of using the same
02/16/2012US20120039892 A34 and a33-like 3 dna protein, antibodies thereto and methods of treatment using same
02/16/2012US20120039891 Methods for diagnosing cancer and decreasing metastasis by cancer cells
02/16/2012US20120039890 Methods of treatment using antibodies to neutrokine-alpha
02/16/2012US20120039889 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion
02/16/2012US20120039888 Methods Of Inhibiting Inflammation-Associated Tissue Damage By Inhibiting Neutrophil Activity
02/16/2012US20120039887 Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript
02/16/2012US20120039886 Use of an immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the abo system
02/16/2012US20120039885 Composition and method for cancer treatment
02/16/2012US20120039884 Compositions and methods for treating cardiovascular disease
02/16/2012US20120039883 Detection and diagnosis of inflammatory disorders
02/16/2012US20120039882 Vascular Disease Therapies
02/16/2012US20120039881 Compositions and methods for treating neurological disorders
02/16/2012US20120039880 FRAGMENTATION RESISTANT IgG1 Fc-CONJUGATES
02/16/2012US20120039879 Streptavidin having low immunogenicity and use thereof
02/16/2012US20120039878 Treatment and prophylaxis of amyloidosis
02/16/2012US20120039877 E1-minus adenoviruses and use thereof
02/16/2012US20120039876 Stabilized liquid anti-rsv antibody formulations
02/16/2012US20120039875 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
02/16/2012US20120039874 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
02/16/2012US20120039873 Antibodies against monocyte chemotactic proteins
02/16/2012US20120039872 Il-3 inhibitors in use for treatment of rheumatoid arthritis in an early stage
02/16/2012US20120039871 Methods and compositions for antibody therapy
02/16/2012US20120039870 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof
02/16/2012US20120039869 Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
02/16/2012US20120039868 Biomarkers for Graft Rejection
02/16/2012US20120039867 Immune System Function in Conditions Characterized by Elevated Double Strand Breaks
02/16/2012US20120039866 Methods of treating pain
02/16/2012US20120039865 Identification of sortilin as a neuronal receptor for the frontotemporal dementia protein, progranulin
02/16/2012US20120039864 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
02/16/2012US20120039849 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
02/16/2012US20120039848 Hepatitis c virus inhibitors
02/16/2012US20120039846 Hepatitis c antibodies and uses thereof
02/16/2012US20120039842 Compositions and methods that enhance an immune response
02/16/2012US20120039841 T-Helper Cell Type 17 Lineage-Specific Adjuvants, Compositions and Methods
02/16/2012US20120039839 Hypoxia Induced Mitogenic Factor
02/16/2012US20120039807 Anti-Tenascin-C A2 Antibodies and Methods of Use
02/16/2012US20120039806 Compounds and Methods for Modulating an Immune Response
02/16/2012US20120039805 Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
02/16/2012US20120039801 SPARC binding peptides and uses thereof
02/16/2012US20120039800 Platinum Acridine Anti-Cancer Compounds And Methods Thereof
02/16/2012US20120039798 Methods of modifying p53 acetylation and treating cancer using avra
02/16/2012US20120039797 Antibody Therapy
02/16/2012CA2808185A1 Antibodies to il-1.beta. and il-18, for treatment of disease
02/16/2012CA2807942A1 Erythrocyte-binding therapeutics
02/16/2012CA2807664A1 Anti-hemagglutinin antibody compositions and methods of use thereof
02/16/2012CA2807616A1 Methods and compositions for preventing a condition
02/16/2012CA2807585A1 Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells
02/16/2012CA2806640A1 Anti-tenascin-c a2 antibodies and methods of use
02/16/2012CA2806447A1 Neuropilin as a biomarker for bevacizumab combination therapies
02/16/2012CA2805114A1 Anti-n3pglu amyloid beta peptide antibodies and uses thereof
02/16/2012CA2804424A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
02/16/2012CA2804416A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
02/16/2012CA2793510A1 Adjuvanted vaccines for serogroup b meningococcus
02/15/2012EP2418223A2 Single-chain multivalent binding proteins with effector function
02/15/2012EP2418222A1 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
02/15/2012EP2418221A1 Specific antibodies to G protein-coupled receptors and method for producing the same
02/15/2012EP2418220A2 Interferon alpha antibodies and their uses
02/15/2012EP2418212A1 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma
02/15/2012EP2417984A1 Method for treatment of blood tumor using anti-tim-3 antibody
02/15/2012EP2417983A1 Multivalent pneumococcal polysaccharide-protein conjugate composition
02/15/2012EP2417974A1 Combination therapy for treatment of immune disorders
02/15/2012EP2417968A1 Particle comprising cytokines, antibodies and polymers and use thereof as medicament for the treatment of cancer
02/15/2012EP2417456A1 Diagnostic mycobacterium tuberculosis test
02/15/2012EP2417251A1 Method for purifying the rabies virus
02/15/2012EP2417165A1 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
02/15/2012EP2417161A1 Antibodies against il-17br
02/15/2012EP2417160A1 Bispecific anti-erbb-1/anti-c-met antibodies
02/15/2012EP2417156A1 Trivalent, bispecific antibodies
02/15/2012EP2416807A1 Novel strategies for improved cancer vaccines
02/15/2012EP2416803A1 New methods for treatment of inflammatory diseases
02/15/2012EP2416802A1 Method for treating immune disorders
02/15/2012EP2416801A1 Immunogenic composition and uses thereof
02/15/2012EP2416798A2 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines
02/15/2012EP2416662A1 Alphavirus replicon particles expressing trp2
02/15/2012EP2094298B1 Multivalent pneumococcal polysaccharide-protein conjugate composition
02/15/2012EP1971680B1 Method for generating dendritic cells employing decreased temperature
02/15/2012EP1966243B1 Tgf-beta binding antibodies
02/15/2012EP1951891B1 Cancer antigen mage-a9 and uses thereof
02/15/2012EP1678212B1 Hypo- and hyper-acetylated meningococcal capsular saccharides
02/15/2012EP1675869B1 Stabilised compositions
02/15/2012EP1648506B1 Method for treating synovial sarcoma
02/15/2012EP1532446B1 G-protein coupled receptor ligands and methods
02/15/2012EP1532161B1 Vectors for expression of hml-2 polypeptides
02/15/2012EP1328293B1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
02/15/2012EP1309705B1 Multivalent target binding protein
02/15/2012EP1071457B1 Polymer particle vaccine delivery system
02/15/2012CN1929862B 拮抗性抗-cd40单克隆抗体治疗慢性淋巴细胞性白血病的应用 Monoclonal antibody antagonist anti -cd40 application to treat chronic lymphocytic leukemia
02/15/2012CN1818053B 活的生物产品 Product living organisms
02/15/2012CN1609617B 诊断与预防严重急性呼吸道综合症（sars）的组合物和方法 Diagnosis and compositions and methods for the prevention of severe acute respiratory syndrome (sars) of
02/15/2012CN102356155A Neil3 peptides and vaccines including the same
1 ... 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 ... 1823